Skin Laboratory PCL (BKK:SKIN) ROE %: -31.95% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:SKIN Skin Laboratory PCL BKK:SKIN
20 GF Score
Price ฿0.88
! 2 Warning Signs
View Full Analysis

What is Skin Laboratory PCL ROE %?

Skin Laboratory PCL BKK:SKIN +3.53% 20 ROE % is -31.95% as of Mar. 2026. GuruFocus rates BKK:SKIN with a GF Score™ of 20/100. The stock has 2 warning signs investors should review. Among 1,924 Consumer Packaged Goods companies, Skin Laboratory PCL ranks worse than 86.75% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Skin Laboratory PCL's annualized net income for the quarter that ended in Mar. 2026 was ฿-31.1 Mil. Skin Laboratory PCL's average Total Stockholders Equity over the quarter that ended in Mar. 2026 was ฿97.3 Mil. Therefore, Skin Laboratory PCL's annualized ROE % for the quarter that ended in Mar. 2026 was -31.95%.

The historical rank and industry rank for Skin Laboratory PCL's ROE % or its related term are showing as below:

BKK:SKIN' s ROE % Range Over the Past 10 Years
Min: -11.11   Med: 15.44   Max: 23.24
Current: -11.11

During the past 4 years, Skin Laboratory PCL's highest ROE % was 23.24%. The lowest was -11.11%. And the median was 15.44%.

BKK:SKIN's ROE % is ranked worse than
86.75% of 1924 companies
in the Consumer Packaged Goods industry
Industry Median: 6.955 vs BKK:SKIN: -11.11

Skin Laboratory PCL  (BKK:SKIN) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=-31.088/97.3015
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-31.088 / 143.472)*(143.472 / 118.5695)*(118.5695 / 97.3015)
=Net Margin %*Asset Turnover*Equity Multiplier
=-21.67 %*1.21*1.2186
=ROA %*Equity Multiplier
=-26.22 %*1.2186
=-31.95 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=-31.088/97.3015
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-31.088 / -29.672) * (-29.672 / -29.576) * (-29.576 / 143.472) * (143.472 / 118.5695) * (118.5695 / 97.3015)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1.0477 * 1.0032 * -20.61 % * 1.21 * 1.2186
=-31.95 %

Note: The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Skin Laboratory PCL ROE % Related Terms


Skin Laboratory PCL ROE % Historical Data

* Premium members only.

The historical data trend for Skin Laboratory PCL's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Skin Laboratory PCL ROE % Chart

Skin Laboratory PCL Annual Data
Trend Dec22 Dec23 Dec24 Dec25
ROE %
14.93 23.24 15.95 5.38

Skin Laboratory PCL Quarterly Data
Dec22 Dec23 Sep24 Dec24 Mar25 Sep25 Dec25 Mar26
ROE % Get a 7-Day Free Trial 56.85 28.48 0.93 -13.67 -31.95

BKK:SKIN vs PG, CL, KVUE: ROE % Comparison

For the Household & Personal Products subindustry, Skin Laboratory PCL's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Skin Laboratory PCL ROE % vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Skin Laboratory PCL's ROE % distribution charts can be found below:

* The bar in red indicates where Skin Laboratory PCL's ROE % falls into.


BKK:SKIN
20GF Score
Skin Laboratory PCL BKK:SKIN
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Skin Laboratory PCL ROE % Calculation

Skin Laboratory PCL's annualized ROE % for the fiscal year that ended in Dec. 2025 is calculated as

ROE %=Net Income (A: Dec. 2025 )/( (Total Stockholders Equity (A: Dec. 2024 )+Total Stockholders Equity (A: Dec. 2025 ))/ count )
=4.378/( (61.688+101.188)/ 2 )
=4.378/81.438
=5.38 %

Skin Laboratory PCL's annualized ROE % for the quarter that ended in Mar. 2026 is calculated as

ROE %=Net Income (Q: Mar. 2026 )/( (Total Stockholders Equity (Q: Dec. 2025 )+Total Stockholders Equity (Q: Mar. 2026 ))/ count )
=-31.088/( (101.188+93.415)/ 2 )
=-31.088/97.3015
=-31.95 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2026) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of -31.95% mean?
Skin Laboratory PCL (BKK:SKIN) has a ROE % of -31.95% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Skin Laboratory PCL and its competitors. According to the industry distribution chart, Skin Laboratory PCL ranks #1669 out of 1924 companies in the Consumer Packaged Goods industry, placing it in the top 86.7%.
Is Skin Laboratory PCL's ROE % too high?
Skin Laboratory PCL's current ROE % is -31.95%. Based on the distribution chart, Skin Laboratory PCL ranks #1669 out of 1924 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Skin Laboratory PCL has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Skin Laboratory PCL's ROE % compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Skin Laboratory PCL ranks #1669 out of 1924 companies for ROE %. This places Skin Laboratory PCL in the lower half of its industry. The industry median ROE % is 6.96. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Consumer Packaged Goods company?
The median ROE % among Consumer Packaged Goods companies is 6.96, based on 1,924 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Skin Laboratory PCL and its competitors. For the Consumer Packaged Goods industry, the median ROE % is 6.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Skin Laboratory PCL's current ROE % is -31.95%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Skin Laboratory PCL stock overvalued right now?
Skin Laboratory PCL (BKK:SKIN) has a current ROE % of -31.95%. The current ROE % is -31.95%. Skin Laboratory PCL's overall GF Score™ is 20/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Skin Laboratory PCL (BKK:SKIN), the current ROE % is -31.95% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Skin Laboratory PCL Business Description

Address Unit P, Popular Road, No. 89, Cosmo Office Park Building, 8th Floor, Ban Mai Subdistrict, Pak Kret District, Nonthaburi, THA, 11120
Skin Laboratory PCL is engaged in the business of inventing, developing, contracting production, and distributing beauty products under the Company's various brands, including facial serum products, sunscreen products, facial cleansers, facial care products, and other products. The Company's core business is only one operating segment, which is manufacturing and distributing skin creams, beauty creams, cosmetics, and operates virtually its business in one geographical location in Thailand.
20GF Score

Get the complete analysis for BKK:SKIN

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿0.88
Price